Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Systems and methods for therapeutically treating neuro-psychiatric disorders and other illnesses

a neuropsychiatric and other illness technology, applied in the field of systems and methods for treating or controlling medical, psychiatric, or neurological disorders and conditions, can solve the problems of selective unidirectional stimulation, ineffective therapy or only marginally effective for some patients, and unmyelinated c fibers

Active Publication Date: 2006-03-09
ZABARA JACOB
View PDF13 Cites 81 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The C fibers, however, are unmyelinated.
However, selective unidirectional stimulation is achievable through the use of special nerve electrodes and stimulating waveforms.
In addition, the therapy is either ineffective or only marginally effective for some patients.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Systems and methods for therapeutically treating neuro-psychiatric disorders and other illnesses
  • Systems and methods for therapeutically treating neuro-psychiatric disorders and other illnesses
  • Systems and methods for therapeutically treating neuro-psychiatric disorders and other illnesses

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0022] In accordance with an embodiment of the present invention, MS allows for an augmentation of present ENS therapies such as VNS by providing MS therapy to a patient before, during, or after the patient is treated with ENS therapy In a preferred embodiment, both MS and ENS therapies are provided to the patient repeatedly. MS allows a range of tissues, such as cranial nerves, to have signal traffic modified by an external magnetic generator. Without being bound by theory, it is believed that using MS therapy in conjunction with ENS therapy improves safety and increases the potential effectiveness of ENS. MS also allows an extension of ENS to treatment of other illnesses such as, for example, cancer and HIV infections by providing a combined action on brain regulatory areas and pathological tissue. MS increases the physiological magnitude of the action to increase possible effectiveness of VNS or the electrical stimulation of other cranial nerves.

[0023]FIG. 1 is a schematic block...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Systems and methods for treating neuro-psychiatric disorders, such as depression or schizophrenia, and / or other illnesses are disclosed. A patient is diagnosed with a particular neuro-psychiatric disorder or other illness. An electric nerve stimulation (ENS) technique, such as vagus nerve stimulation (VNS), is administered to the patient in conjunction with a magnetic nerve stimulation (MNS) technique. The magnetic nerve stimulation (MNS) technique includes applying a magnetic field to a pre-selected synaptic region of a brain of the patient based on the diagnosis. A physiological response of the brain, such as electroencephalogram (EEG) activity, is monitored. One or more parameters of the magnetic field may be selectively adapted in response to the monitored physiological response. The administration of the ENS technique and the MNS technique may be performed simultaneously, in serial order, or in alternating order depending on the diagnosis.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS / INCORPORATION BY REFERENCE [0001] This application claims priority to U.S. provisional patent application Ser. No. ______ filed on Dec. 30, 2003, Express Mail number EV415640672US. [0002] U.S. Pat. No. 5,299,569 issued on Apr. 5, 1994 is incorporated by reference herein in its entirety. U.S. Pat. No. 5,540,734 issued on Jul. 30, 1996 is incorporated by reference herein in its entirety. U.S. Pat. No. 6,132,361 issued on Oct. 17, 2000 is incorporated by reference herein in its entirety. U.S. Pat. No. 6,266,556 issued on Jul. 24, 2001 is incorporated by reference herein in its entirety.TECHNICAL FIELD [0003] The present invention relates to systems and methods for treating or controlling medical, psychiatric, or neurological disorders and conditions. More particularly, certain embodiments of the present invention relate to using an electric nerve stimulation (ENS) technique in conjunction with a magnetic stimulation (MS) technique to treat the di...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61N1/00A61N1/18A61B13/00A61N1/36A61N2/00
CPCA61N1/36025A61N1/36053A61N2/006A61N1/36082
Inventor ZABARA, JACOB
Owner ZABARA JACOB
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products